Serialisation Lessons from Türkiye's İTS and the EU FMD

How Türkiye's İTS and the EU Falsified Medicines Directive run serialisation, and what supplement and cosmetics brands can learn.

Türkiye's Pharmaceutical Track and Trace System (İTS) records every medicine pack at every change of hands along the chain. The European Union's Falsified Medicines Directive (FMD) uploads the code at manufacture, then verifies and closes it when the pack is dispensed. The two models are built differently but rest on the same two principles: each pack gets a unique identity that cannot be guessed, and that identity can be consumed only once. Food supplement and cosmetics brands can apply those principles at their own level of risk, even where no regulation requires it.

Medicines led the way here because counterfeiting touches patient health directly. According to the World Health Organization's 2017 estimate, at least one in 10 medicines in low- and middle-income countries is substandard or falsified, and around USD 30.5 billion a year is spent on such products.

How does İTS track every pack?

According to the Turkish Medicines and Medical Devices Agency (TİTCK), İTS is an adaptation of track-and-trace systems used worldwide to the pharmaceutical sector. The Ministry of Health rolled it out nationwide in 2010. The inbound and outbound movements of every medicine pack are notified through a data matrix code; the product's latest location, time and status are held in a database.

As reported by the Pharmaceutical Manufacturers Association (İEİS), the data matrix code became mandatory for all products manufactured from 1 January 2010; products made before that date without a code could be sold until 1 July 2010. In 2012 an identification requirement was introduced for transport packaging as well. İEİS notes that İTS was applied at this scope for the first time in the world in Türkiye.

The code is a two-dimensional DataMatrix symbol carrying four pieces of data: the product's barcode number (GTIN), the serial number, the expiry date and the batch number.

According to TİTCK, the system covers prescription and non-prescription medicines and medical nutrition products; saline solutions, radiopharmaceuticals and magistral preparations are out of scope. Notifications are made by manufacturers, importers, pharmaceutical warehouses, pharmacies, hospitals and reimbursement institutions. The system's aims include preventing the sale of falsified and smuggled medicines, patient safety and preventing coupon fraud.

FMD: verification at both ends of the chain

In the EU the framework is set by Directive 2011/62/EU, adopted on 8 June 2011, which amends Directive 2001/83/EC. As a rule the directive requires two safety features on the packaging of prescription medicines: a unique identifier and an anti-tampering device. For non-prescription medicines these features are required only where the risk of falsification is found to be high. The directive also introduces a common EU logo for legally operating online pharmacies and a registration obligation for medicine brokers.

The technical details sit in Delegated Regulation (EU) 2016/161. Under the rules, which have applied since 9 February 2019:

  • The unique identifier consists of the product code, a serial number of at most 20 characters, a national reimbursement number where required, the batch number and the expiry date.
  • The probability of guessing the serial number must be negligible; the numbers are generated randomly rather than sequentially.
  • The code is printed as a Data Matrix compliant with ISO/IEC 16022, and print quality must exceed a given threshold. Where the packaging allows, the data also appears in human-readable form.
  • The codes are connected to national and supranational repositories through a central data routing hub.
  • Pharmacies and healthcare institutions verify the code and decommission it when dispensing the product. The same code cannot be used a second time; under certain conditions the operation can be reversed within 10 days.
  • Wholesalers must verify returned products and products coming from outside authorised sources.

Where do the two architectures differ?

İTS records every change of hands along the chain. The FMD puts the weight on the two ends: codes are uploaded to the system and verified and decommissioned at the point of dispensing, while wholesaler checks in between are limited to defined risk situations. İTS gives more data and visibility; the FMD runs a leaner operation. The common ground is the same: an identity specific to the pack, impossible to guess and consumed once.

The general flow that comes out of both systems has six steps:

  1. Identity generation: the product code (GTIN), a random serial number, the batch and the expiry date are created together.
  2. Printing and checking: the code is printed on the production line and its readability and print quality are checked.
  3. Registration: the identities created are notified to the central system.
  4. Events along the chain: warehouse, distributor and point-of-sale notifications (İTS) or risk-based checks (FMD) take place.
  5. Verification at the final point: the code is verified and closed when the product is handed to the end user.
  6. Anomaly detection: when a code that has already been closed, or was never registered, is scanned, the system raises an alert.

Counterfeits are caught mostly in the last two steps. A copied code shows up as an identity seen a second time, because the genuine product has already been registered or consumed. The anti-tampering device covers the case where the code is correct but the contents have been changed.

What is the situation for supplements and cosmetics?

In these categories the framework runs through different institutions. Food supplements fall under the Ministry of Agriculture and Forestry's food legislation. Since 2 October 2024 the ministry has published imitated or adulterated foods and products that may endanger health, as identified in inspections, in real time on its Reliable Food portal. Cosmetic products are registered in the Product Tracking System (ÜTS), which TİTCK runs alongside medical devices and biocidal products.

These mechanisms were set up for registration and market surveillance. For a brand to verify its own product in the field at pack level and to see channel movements usually takes a separate structure.

The risk exists in these categories too. The 2025 OECD and EUIPO report lists cosmetics, alongside pharmaceuticals, food and toys, among the counterfeit product categories carrying health and safety risks. The WHO notes that sales of medical products through unauthorised websites make it easier for falsified products to reach consumers.

Which rules carry over from medicines?

  • An unguessable number: sequential numbers are easy to derive. The FMD's requirement for random serial numbers is a good benchmark for voluntary schemes as well.
  • Single-use verification: closing the code when it reaches the end user, or flagging scans after the first one, makes a copied code visible.
  • Pairing the code with physical security: the FMD requires the unique identifier together with an anti-tampering device, an acknowledgement that a printed code is not enough on its own.
  • A standard identifier: according to GS1, GS1 DataMatrix is used to meet pharmaceutical traceability legislation in more than 75 countries, including Türkiye. A standard code makes integration with business partners easier.
  • Tying transport packaging to the product: the extension of İTS to transport packaging shows that linking case and pallet identities to individual products works in practice.
  • Starting where the risk is: without an obligation there is no need to start with the whole portfolio. The products most exposed to counterfeiting and with the highest unit value come first.

How does Spectrace apply these principles?

Tagvex records every change of hands from the line to the warehouse, the dealer and the customer with a unique number for each product, or each batch, and flags a copied code as an unexpected or repeated scan. Grafex makes the packaging itself verifiable with an invisible signature embedded in the existing design. Staff, dealers and consumers verify with a smartphone. These records are for the brand's own use; they do not replace the official notification obligations that arise from İTS, ÜTS or food legislation.

Sources

pharmaceutical track and traceserialisationfmdfood supplementscosmetics

Request a meeting

The right solution for your product follows from a needs analysis.

In the first meeting we review your product, sales channels and the risks you face, then recommend a verification method that fits.

Request a meeting